Annual EBIT
-$42.00 M
-$5.26 M-14.33%
September 30, 2024
Summary
- As of February 8, 2025, CTXR annual earnings before interest & taxes is -$42.00 million, with the most recent change of -$5.26 million (-14.33%) on September 30, 2024.
- During the last 3 years, CTXR annual EBIT has fallen by -$18.95 million (-82.24%).
- CTXR annual EBIT is now -214163.78% below its all-time high of -$19.60 thousand, reached on September 30, 2012.
Performance
CTXR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$11.05 M
-$416.30 K-3.91%
September 30, 2024
Summary
- As of February 8, 2025, CTXR quarterly earnings before interest & taxes is -$11.05 million, with the most recent change of -$416.30 thousand (-3.91%) on September 30, 2024.
- Over the past year, CTXR quarterly EBIT has dropped by -$416.30 thousand (-3.91%).
- CTXR quarterly EBIT is now -1841650.00% below its all-time high of -$600.00, reached on December 31, 2012.
Performance
CTXR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$42.00 M
-$925.80 K-2.25%
September 30, 2024
Summary
- As of February 8, 2025, CTXR TTM earnings before interest & taxes is -$42.00 million, with the most recent change of -$925.80 thousand (-2.25%) on September 30, 2024.
- Over the past year, CTXR TTM EBIT has dropped by -$925.80 thousand (-2.25%).
- CTXR TTM EBIT is now -466518.89% below its all-time high of -$9000.00, reached on December 31, 2010.
Performance
CTXR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CTXR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.3% | -3.9% | -2.3% |
| 3 y3 years | -82.2% | -3.9% | -2.3% |
| 5 y5 years | -170.1% | -3.9% | -2.3% |
CTXR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -82.2% | at low | -52.4% | at low | -73.8% | at low |
| 5 y | 5-year | -170.1% | at low | -168.4% | at low | -162.6% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
Citius Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$42.00 M(+14.3%) | -$11.05 M(+3.9%) | -$42.00 M(+2.3%) |
| Jun 2024 | - | -$10.63 M(-3.1%) | -$41.07 M(+5.0%) |
| Mar 2024 | - | -$10.97 M(+17.4%) | -$39.11 M(+0.7%) |
| Dec 2023 | - | -$9.34 M(-7.7%) | -$38.82 M(+5.7%) |
| Sep 2023 | -$36.73 M(+10.3%) | -$10.12 M(+16.8%) | -$36.73 M(+7.5%) |
| Jun 2023 | - | -$8.67 M(-18.8%) | -$34.16 M(-0.7%) |
| Mar 2023 | - | -$10.69 M(+47.4%) | -$34.40 M(+9.9%) |
| Dec 2022 | - | -$7.25 M(-4.0%) | -$31.31 M(-6.0%) |
| Sep 2022 | - | -$7.55 M(-15.3%) | -$33.32 M(+8.4%) |
| Sep 2022 | -$33.32 M(+44.6%) | - | - |
| Jun 2022 | - | -$8.92 M(+17.5%) | -$30.73 M(+11.2%) |
| Mar 2022 | - | -$7.59 M(-18.0%) | -$27.63 M(+14.4%) |
| Dec 2021 | - | -$9.26 M(+86.6%) | -$24.16 M(+4.8%) |
| Sep 2021 | -$23.04 M(+31.4%) | -$4.96 M(-14.8%) | -$23.04 M(+3.8%) |
| Jun 2021 | - | -$5.82 M(+41.3%) | -$22.20 M(+5.4%) |
| Mar 2021 | - | -$4.12 M(-49.4%) | -$21.05 M(-1.4%) |
| Dec 2020 | - | -$8.14 M(+97.8%) | -$21.36 M(+21.8%) |
| Sep 2020 | -$17.53 M(+12.8%) | -$4.12 M(-11.9%) | -$17.53 M(+2.8%) |
| Jun 2020 | - | -$4.68 M(+5.8%) | -$17.06 M(+1.6%) |
| Mar 2020 | - | -$4.42 M(+2.4%) | -$16.79 M(+5.0%) |
| Dec 2019 | - | -$4.32 M(+18.5%) | -$15.99 M(+2.9%) |
| Sep 2019 | -$15.55 M(+24.2%) | -$3.65 M(-17.2%) | -$15.55 M(+5.4%) |
| Jun 2019 | - | -$4.40 M(+21.3%) | -$14.74 M(+19.3%) |
| Mar 2019 | - | -$3.63 M(-6.3%) | -$12.36 M(-6.0%) |
| Dec 2018 | - | -$3.87 M(+36.1%) | -$13.15 M(+5.0%) |
| Sep 2018 | -$12.52 M | -$2.84 M(+40.9%) | -$12.52 M(+4.9%) |
| Jun 2018 | - | -$2.02 M(-54.3%) | -$11.94 M(-3.0%) |
| Mar 2018 | - | -$4.42 M(+36.2%) | -$12.31 M(+16.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | - | -$3.24 M(+43.5%) | -$10.61 M(+11.3%) |
| Sep 2017 | -$9.53 M(+15.1%) | -$2.26 M(-5.4%) | -$9.53 M(-3.3%) |
| Jun 2017 | - | -$2.39 M(-12.3%) | -$9.86 M(-11.0%) |
| Mar 2017 | - | -$2.72 M(+25.9%) | -$11.08 M(+20.1%) |
| Dec 2016 | - | -$2.16 M(-16.3%) | -$9.23 M(+11.4%) |
| Sep 2016 | -$8.29 M(+186.3%) | -$2.58 M(-28.4%) | -$8.29 M(+25.4%) |
| Jun 2016 | - | -$3.61 M(+315.4%) | -$6.61 M(+72.9%) |
| Mar 2016 | - | -$869.50 K(-28.8%) | -$3.82 M(+15.9%) |
| Dec 2015 | - | -$1.22 M(+34.4%) | -$3.30 M(+14.0%) |
| Sep 2015 | -$2.89 M(>+9900.0%) | -$908.30 K(+10.1%) | -$2.89 M(+45.7%) |
| Jun 2015 | - | -$825.00 K(+138.9%) | -$1.99 M(+70.8%) |
| Mar 2015 | - | -$345.30 K(-57.7%) | -$1.16 M(+34.1%) |
| Dec 2014 | - | -$816.20 K(>+9900.0%) | -$867.30 K(+53.5%) |
| Jun 2014 | - | -$1300.00(-97.4%) | -$565.00 K(-0.4%) |
| Mar 2014 | - | -$49.80 K(-90.0%) | -$567.10 K(+7.7%) |
| Dec 2013 | - | -$499.20 K(+3295.9%) | -$526.60 K(+1780.7%) |
| Sep 2013 | -$28.10 K(+43.4%) | -$14.70 K(+332.4%) | -$28.00 K(+57.3%) |
| Jun 2013 | - | -$3400.00(-63.4%) | -$17.80 K(-13.6%) |
| Mar 2013 | - | -$9300.00(+1450.0%) | -$20.60 K(+14.4%) |
| Dec 2012 | - | -$600.00(-86.7%) | -$18.00 K(-8.2%) |
| Sep 2012 | -$19.60 K(-23.4%) | -$4500.00(-27.4%) | -$19.60 K(+12.0%) |
| Jun 2012 | - | -$6200.00(-7.5%) | -$17.50 K(-4.9%) |
| Mar 2012 | - | -$6700.00(+204.5%) | -$18.40 K(-2.1%) |
| Dec 2011 | - | -$2200.00(-8.3%) | -$18.80 K(-26.6%) |
| Sep 2011 | -$25.60 K | -$2400.00(-66.2%) | -$25.60 K(+10.3%) |
| Jun 2011 | - | -$7100.00(0.0%) | -$23.20 K(+44.1%) |
| Mar 2011 | - | -$7100.00(-21.1%) | -$16.10 K(+78.9%) |
| Dec 2010 | - | -$9000.00 | -$9000.00 |
FAQ
- What is Citius Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual EBIT year-on-year change?
- What is Citius Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly EBIT year-on-year change?
- What is Citius Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals TTM EBIT year-on-year change?
What is Citius Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of CTXR is -$42.00 M
What is the all time high annual EBIT for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual earnings before interest & taxes is -$19.60 K
What is Citius Pharmaceuticals annual EBIT year-on-year change?
Over the past year, CTXR annual earnings before interest & taxes has changed by -$5.26 M (-14.33%)
What is Citius Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of CTXR is -$11.05 M
What is the all time high quarterly EBIT for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$600.00
What is Citius Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, CTXR quarterly earnings before interest & taxes has changed by -$416.30 K (-3.91%)
What is Citius Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of CTXR is -$42.00 M
What is the all time high TTM EBIT for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high TTM earnings before interest & taxes is -$9000.00
What is Citius Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, CTXR TTM earnings before interest & taxes has changed by -$925.80 K (-2.25%)